Sanofi, WC Heraeus Drop Patent Spat Over Eloxatin

By Jocelyn Allison

Law360, New York (September 01, 2010, 6:06 PM ET) -- Sanofi-Aventis U.S. LLC has agreed to release German precious metals company W.C. Heraeus GmbH from a lawsuit accusing several generic-drug makers of infringing the patents for the colon cancer drug Eloxatin.

Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey issued an order Tuesday dismissing the claims without prejudice based on a stipulation of dismissal the parties submitted last week.

The order did not provide further details about the stipulation except to say that both parties agreed to cover their...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles